v3.26.1
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS’ EQUITY - EUR (€)
€ in Thousands
Total
SHARE CAPITAL
PREMIUMS RELATED TO SHARE CAPITAL
TRANSLATION RESERVE
RETAINED EARNINGS
NET LOSS FOR THE YEAR
Number of shares issued at beginning of period (in shares) at Dec. 31, 2024 63,347,837          
Reconciliation of number of shares outstanding [abstract]            
Issue of free shares (in shares) 70,912          
Number of shares issued at end of period (in shares) at Mar. 31, 2025 63,418,749          
Equity at beginning of period at Dec. 31, 2024 € 40,584 € 633 € 478,905 € (75) € (262,637) € (176,242)
Changes in equity [abstract]            
Net loss for the period (52,370)         (52,370)
Other comprehensive income (loss) 250     211 40  
Total comprehensive income (loss) for the period (52,119)     211 40 (52,370)
Appropriation of prior period net loss 0       (176,242) 176,242
Exercises of share warrants and other share warrants 250   250      
Issue of free shares 0 1 (1)      
Shares based compensation expense 4,692       4,692  
Equity at end of period at Mar. 31, 2025 € (6,591) 634 479,155 136 (434,147) (52,370)
Number of shares issued at beginning of period (in shares) at Dec. 31, 2025 78,536,412          
Reconciliation of number of shares outstanding [abstract]            
Exercises of share warrants (in shares) 2,540          
Issue of free shares (in shares) 752,236          
Number of shares issued at end of period (in shares) at Mar. 31, 2026 79,291,188          
Equity at beginning of period at Dec. 31, 2025 € 455,205 785 1,190,593 2,309 (402,380) (336,102)
Changes in equity [abstract]            
Net loss for the period (48,468)         (48,468)
Other comprehensive income (loss) (252)     (280) 29  
Total comprehensive income (loss) for the period (48,720)     (280) 29 (48,468)
Appropriation of prior period net loss 0       (336,102) 336,102
Issue of share warrants 475   475      
Exercises of share warrants and other share warrants 23   23      
Issue of free shares 0 8 (8)      
Shares based compensation expense 22,610       22,610  
Equity at end of period at Mar. 31, 2026 € 429,594 € 793 € 1,191,083 € 2,029 € (715,843) € (48,468)